Global Meningococcal Vaccines Market Insights, Forecast to 2025

Publisher Name :
Date: 01-Feb-2019
No. of pages: 110
Inquire Before Buying

The global Meningococcal Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Meningococcal Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Meningococcal Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Vaccines in these regions.

This research report categorizes the global Meningococcal Vaccines market by top players/brands, region, type and end user. This report also studies the global Meningococcal Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- GlaxoSmithKline

- JN-International Medical

- Novartis International

- Sanofi

- Pfizer

- Baxter International

Market size by Product

- Menactra

- Menomune

Market size by End User

- Pneumonia

- Meningitis

- Bacteremia

- Others (Arthritis, Conjunctivitis, Urethritis)

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Meningococcal Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Meningococcal Vaccines market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Meningococcal Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Meningococcal Vaccines submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Meningococcal Vaccines are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Meningococcal Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Meningococcal Vaccines Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Meningococcal Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Meningococcal Vaccines Market Size Growth Rate by Product
1.4.2 Menactra
1.4.3 Menomune
1.5 Market by End User
1.5.1 Global Meningococcal Vaccines Market Size Growth Rate by End User
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Bacteremia
1.5.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Meningococcal Vaccines Market Size
2.1.1 Global Meningococcal Vaccines Revenue 2014-2025
2.1.2 Global Meningococcal Vaccines Sales 2014-2025
2.2 Meningococcal Vaccines Growth Rate by Regions
2.2.1 Global Meningococcal Vaccines Sales by Regions
2.2.2 Global Meningococcal Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Meningococcal Vaccines Sales by Manufacturers
3.1.1 Meningococcal Vaccines Sales by Manufacturers
3.1.2 Meningococcal Vaccines Sales Market Share by Manufacturers
3.1.3 Global Meningococcal Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Meningococcal Vaccines Revenue by Manufacturers
3.2.1 Meningococcal Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Meningococcal Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Meningococcal Vaccines Price by Manufacturers
3.4 Meningococcal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Meningococcal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Meningococcal Vaccines Sales by Product
4.2 Global Meningococcal Vaccines Revenue by Product
4.3 Meningococcal Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Meningococcal Vaccines Breakdown Data by End User
6 North America
6.1 North America Meningococcal Vaccines by Countries
6.1.1 North America Meningococcal Vaccines Sales by Countries
6.1.2 North America Meningococcal Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Meningococcal Vaccines by Product
6.3 North America Meningococcal Vaccines by End User
7 Europe
7.1 Europe Meningococcal Vaccines by Countries
7.1.1 Europe Meningococcal Vaccines Sales by Countries
7.1.2 Europe Meningococcal Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningococcal Vaccines by Product
7.3 Europe Meningococcal Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Meningococcal Vaccines by Countries
8.1.1 Asia Pacific Meningococcal Vaccines Sales by Countries
8.1.2 Asia Pacific Meningococcal Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Meningococcal Vaccines by Product
8.3 Asia Pacific Meningococcal Vaccines by End User
9 Central & South America
9.1 Central & South America Meningococcal Vaccines by Countries
9.1.1 Central & South America Meningococcal Vaccines Sales by Countries
9.1.2 Central & South America Meningococcal Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Meningococcal Vaccines by Product
9.3 Central & South America Meningococcal Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Vaccines by Countries
10.1.1 Middle East and Africa Meningococcal Vaccines Sales by Countries
10.1.2 Middle East and Africa Meningococcal Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Meningococcal Vaccines by Product
10.3 Middle East and Africa Meningococcal Vaccines by End User
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline Meningococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GlaxoSmithKline Meningococcal Vaccines Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 JN-International Medical
11.2.1 JN-International Medical Company Details
11.2.2 Company Business Overview
11.2.3 JN-International Medical Meningococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 JN-International Medical Meningococcal Vaccines Products Offered
11.2.5 JN-International Medical Recent Development
11.3 Novartis International
11.3.1 Novartis International Company Details
11.3.2 Company Business Overview
11.3.3 Novartis International Meningococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis International Meningococcal Vaccines Products Offered
11.3.5 Novartis International Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Meningococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Meningococcal Vaccines Products Offered
11.4.5 Sanofi Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Meningococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Meningococcal Vaccines Products Offered
11.5.5 Pfizer Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Company Business Overview
11.6.3 Baxter International Meningococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Baxter International Meningococcal Vaccines Products Offered
11.6.5 Baxter International Recent Development
12 Future Forecast
12.1 Meningococcal Vaccines Market Forecast by Regions
12.1.1 Global Meningococcal Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Meningococcal Vaccines Revenue Forecast by Regions 2019-2025
12.2 Meningococcal Vaccines Market Forecast by Product
12.2.1 Global Meningococcal Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Meningococcal Vaccines Revenue Forecast by Product 2019-2025
12.3 Meningococcal Vaccines Market Forecast by End User
12.4 North America Meningococcal Vaccines Forecast
12.5 Europe Meningococcal Vaccines Forecast
12.6 Asia Pacific Meningococcal Vaccines Forecast
12.7 Central & South America Meningococcal Vaccines Forecast
12.8 Middle East and Africa Meningococcal Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningococcal Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Meningococcal Vaccines Product Picture
Table Meningococcal Vaccines Market Segments
Table Key Manufacturers Meningococcal Vaccines Covered
Table Global Meningococcal Vaccines Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Meningococcal Vaccines Sales Market Share by Product 2014-2025
Figure Menactra Product Picture
Table Major Manufacturers of Menactra
Figure Menomune Product Picture
Table Major Manufacturers of Menomune
Table Global Meningococcal Vaccines Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Pneumonia
Figure Meningitis
Figure Bacteremia
Figure Others (Arthritis, Conjunctivitis, Urethritis)
Figure Meningococcal Vaccines Report Years Considered
Figure Global Meningococcal Vaccines Market Size 2014-2025 (Million US$)
Figure Global Meningococcal Vaccines Sales 2014-2025 (K Units)
Table Global Meningococcal Vaccines Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Meningococcal Vaccines Sales by Regions 2014-2019 (K Units)
Table Global Meningococcal Vaccines Sales Market Share by Regions 2014-2019
Figure Global Meningococcal Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Meningococcal Vaccines Sales Market Share by Regions
Table Global Meningococcal Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Meningococcal Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Meningococcal Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Meningococcal Vaccines Revenue Market Share by Regions
Table Global Meningococcal Vaccines Sales by Manufacturers (2014-2019) (K Units)
Table Global Meningococcal Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Meningococcal Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Meningococcal Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Meningococcal Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Meningococcal Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Meningococcal Vaccines Price (2014-2019) (USD/Unit)
Table Meningococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Meningococcal Vaccines Product Type
Table Date of International Manufacturers Enter into Meningococcal Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Meningococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Global Meningococcal Vaccines Sales Share by Product (2014-2019)
Figure Global Meningococcal Vaccines Sales Market Share by Product (2014-2019)
Figure Global Meningococcal Vaccines Sales Market Share by Product in 2018
Table Global Meningococcal Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Meningococcal Vaccines Revenue Share by Product (2014-2019)
Figure Global Meningococcal Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Meningococcal Vaccines Revenue Market Share by Product in 2018
Table Meningococcal Vaccines Price by Product 2014-2019 (USD/Unit)
Table Global Meningococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Global Meningococcal Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Meningococcal Vaccines Market Share by End User (2014-2019)
Figure Global Sales Meningococcal Vaccines Market Share by End User in 2018
Figure North America Meningococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure North America Meningococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Meningococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table North America Meningococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Meningococcal Vaccines Sales Market Share by Countries
Table North America Meningococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Meningococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Meningococcal Vaccines Revenue Market Share by Countries
Figure United States Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure United States Meningococcal Vaccines Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Canada Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Meningococcal Vaccines Sales by Product (2014-2019) (K Units)
Table North America Meningococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Meningococcal Vaccines Market Share by Product
Table North America Meningococcal Vaccines Sales by End User (2014-2019) (K Units)
Table North America Meningococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Meningococcal Vaccines Market Share by End User
Figure Europe Meningococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Europe Meningococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Meningococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table Europe Meningococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Meningococcal Vaccines Sales Market Share by Countries
Table Europe Meningococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Meningococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Meningococcal Vaccines Revenue Market Share by Countries
Figure Germany Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Germany Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure France Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure UK Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Italy Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Russia Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Meningococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Europe Meningococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Meningococcal Vaccines Market Share by Product
Table Europe Meningococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Europe Meningococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Meningococcal Vaccines Market Share by End User
Figure Asia Pacific Meningococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Meningococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Meningococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Meningococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Meningococcal Vaccines Sales Market Share by Countries
Table Asia Pacific Meningococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Meningococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Meningococcal Vaccines Revenue Market Share by Countries
Figure China Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure China Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Japan Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Korea Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure India Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Australia Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Meningococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Asia Pacific Meningococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Meningococcal Vaccines Market Share by Product
Table Asia Pacific Meningococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Asia Pacific Meningococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Meningococcal Vaccines Market Share by End User
Figure Central & South America Meningococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Meningococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Meningococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table Central & South America Meningococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Meningococcal Vaccines Sales Market Share by Countries
Table Central & South America Meningococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Meningococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Meningococcal Vaccines Revenue Market Share by Countries
Figure Brazil Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Meningococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Central & South America Meningococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Meningococcal Vaccines Market Share by Product
Table Central & South America Meningococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Central & South America Meningococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Meningococcal Vaccines Market Share by End User
Figure Middle East and Africa Meningococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Meningococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Meningococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Meningococcal Vaccines Sales Market Share by Countries
Table Middle East and Africa Meningococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Meningococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Meningococcal Vaccines Revenue Market Share by Countries
Figure GCC Countries Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Meningococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Meningococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Meningococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Meningococcal Vaccines Market Share by Product
Table Middle East and Africa Meningococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Meningococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Meningococcal Vaccines Market Share by End User
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Meningococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table JN-International Medical Company Details
Table JN-International Medical Meningococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table JN-International Medical Recent Development
Table Novartis International Company Details
Table Novartis International Meningococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis International Recent Development
Table Sanofi Company Details
Table Sanofi Meningococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Meningococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Baxter International Company Details
Table Baxter International Meningococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter International Recent Development
Table Global Meningococcal Vaccines Sales Forecast by Regions 2019-2025 (K Units)
Table Global Meningococcal Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Meningococcal Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Meningococcal Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Meningococcal Vaccines Sales Forecast by Product 2019-2025 (K Units)
Table Global Meningococcal Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Meningococcal Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Meningococcal Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Meningococcal Vaccines Sales Forecast by End User 2019-2025 (K Units)
Table Global Meningococcal Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Meningococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Meningococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Meningococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Meningococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Meningococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Meningococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Meningococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Meningococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Meningococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Meningococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Meningococcal Vaccines Value Chain
Table Meningococcal Vaccines Customers List
Table Meningococcal Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Influenza Vaccine Market Insights, Forecast to 2025
    Published: 17-May-2019        Price: US 3900 Onwards        Pages: 120
    Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five year......
  • Global Avian Influenza Vaccines Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 14-May-2019        Price: US 2600 Onwards        Pages: 154
    In this report, we analyze the Avian Influenza Vaccines industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also ......
  • Global Haemophilus B Conjugate Vaccine Industry Market Research Report
    Published: 02-May-2019        Price: US 2960 Onwards        Pages: 129
    The Haemophilus B Conjugate Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Haemophilus B Conjugate Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Haemophilus B Conjugate Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvan......
  • Global (United States, European Union and China) Meningococcal Vaccines Market Research Report 2019-2025
    Published: 02-May-2019        Price: US 3280 Onwards        Pages: 119
    In 2019, the market size of Meningococcal Vaccines is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Meningococcal Vaccines. This report studies the global market ......
  • Global Rubella Vaccine Industry Market Research Report
    Published: 02-May-2019        Price: US 2960 Onwards        Pages: 111
    The Rubella Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Rubella Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Rubella Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry developme......
  • Global Dpt Vaccine Industry Market Research Report
    Published: 02-May-2019        Price: US 2960 Onwards        Pages: 136
    The Dpt Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Dpt Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Dpt Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2......
  • Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025
    Published: 29-Apr-2019        Price: US 1533 Onwards        Pages: 210
    The global influenza vaccines market size is expected to surpass USD 6 billion by 2025. “Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outl......
  • Global Encephalitis Vaccination Market Data Survey Report 2013-2025
    Published: 27-Apr-2019        Price: US 1500 Onwards        Pages: 66
    Summary The global Encephalitis Vaccination market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are included based on company......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Data Survey Report 2013-2025
    Published: 25-Apr-2019        Price: US 1500 Onwards        Pages: 54
    Summary The global 23-Valent Pneumococcal Polysaccharide Vaccine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are incl......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs